Related Experiment Videos
Delayed neuronal death following perinatal asphyxia in rat
E Dell'Anna1, Y Chen, E Engidawork
1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Experimental Brain Research
|June 1, 1997
Summary
Perinatal asphyxia in rat pups causes delayed neuronal death, indicated by DNA fragmentation, particularly in the frontal cortex, striatum, and cerebellum. This cell death appears to be an active, apoptosis-like process, not necrosis or inflammation.
Area of Science:
- Neuroscience
- Developmental Biology
- Pathology
Background:
- Perinatal asphyxia is a significant cause of neonatal brain injury.
- Understanding the mechanisms of neuronal death following asphyxia is crucial for developing interventions.
Purpose of the Study:
- To investigate the long-term consequences of perinatal asphyxia on the developing rat brain.
- To characterize the pattern and timing of neuronal cell death after asphyxia.
Main Methods:
- Induction of perinatal asphyxia in Sprague-Dawley rat fetuses.
- Histochemical analysis using hematoxylin-eosin and in situ DNA double-strand-breaks labeling.
- Evaluation of brain tissue at various time points post-delivery (80 min to 8 days).
Main Results:
- Perinatal asphyxia led to decreased survival rates, proportional to insult duration.
- No gross morphological changes were observed, but DNA fragmentation (chromatin fragmentation) was detected.
- Asphyctic pups showed delayed, progressive nuclear fragmentation, indicating neuronal death, most prominent in the frontal cortex, striatum, and cerebellum by postnatal day 8.
- Control pups exhibited nuclear fragmentation related to normal brain maturation (programmed cell death).
Conclusions:
- Perinatal asphyxia induces delayed neuronal death in specific brain regions of rat pups.
- The observed neuronal cell death is an active, apoptosis-like phenomenon, distinct from necrosis or inflammation.
- The findings highlight the vulnerability of the developing brain to hypoxic-ischemic injury and suggest potential therapeutic targets.